{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:27:14Z","timestamp":1781731634932,"version":"3.54.5"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>STUDY QUESTION<\/jats:title><jats:p>Does the method of fertilisation improve reproductive outcomes in poor ovarian response (POR) cycles when compared to all other ovarian response categories in the absence of male factor subfertility?<\/jats:p><\/jats:sec><jats:sec><jats:title>SUMMARY ANSWER<\/jats:title><jats:p>ICSI does not confer any benefit in improving the clinical pregnancy or live birth (LB) outcome in autologous ovarian response cycles in the absence of male factor subfertility when compared to IVF.<\/jats:p><\/jats:sec><jats:sec><jats:title>WHAT IS KNOWN ALREADY<\/jats:title><jats:p>ICSI is associated with an improved outcome when compared to IVF in patients with severe male factor subfertility.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title><jats:p>A retrospective study involving 1\u2009376\u2009454 ART cycles, of which 569\u2009605 (41.4%) cycles fulfilled the inclusion and exclusion criteria for all autologous ovarian response categories: 272 433 (47.8%) IVF cycles and 297\u2009172 (52.2%) ICSI cycles. Of these, the POR cohort represented 62\u2009641 stimulated fresh cycles (11.0%): 33 436 (53.4%) IVF cycles and 29\u2009205 (46.6%) ICSI cycles.<\/jats:p><\/jats:sec><jats:sec><jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHOD<\/jats:title><jats:p>All cycles recorded on the anonymised Human Fertilisation and Embryology Authority (HFEA) registry database between 1991 and 2016 were analysed. All fresh cycles with normal sperm parameters, performed after 1998 were included: frozen cycles, donor oocyte and sperm usage, intrauterine insemination cycles, preimplantation genetic testing (PGT) for aneuploidies (PGT-A), PGT for monogenic\/single gene defects (PGT-M), PGT for chromosomal structural arrangements (PGT-SR) cycles, where the reason for stimulation was for storage and unstimulated cycles were excluded.<\/jats:p><\/jats:sec><jats:sec><jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title><jats:p>ICSI did not confer any benefit in improving the LB outcome when compared to conventional IVF per treatment cycle (PTC), when adjusted for female age, number of previous ART treatment cycles, number of previous live births through ART, oocyte yield, stage of transfer, method of fertilisation and number of embryos transferred in the POR cohort (adjusted odds ratio [a OR] 1.03, 99.5% confidence interval [CI] 0.96\u20131.11, P\u00a0=\u20090.261) and all autologous ovarian response categories (aOR 1.00, 99.5% CI 0.98\u20131.02, P\u00a0=\u20090.900). The mean fertilisation rate was statistically lower for IVF treatment cycles (64.7%) when compared to ICSI treatment cycles (67.2%) in the POR cohort (mean difference \u22122.5%, 99.5% CI \u22123.3 to \u22121.6, P\u00a0&amp;lt;\u20090.001). The failed fertilisation rate was marginally higher in IVF treatment cycles (17.3%, 95% binomial exact 16.9 to 17.7%) when compared to ICSI treatment cycles (17.0%, 95% binomial exact 16.6 to 17.4%); however, this did not reach statistical significance (P\u00a0=\u20090.199). The results followed a similar trend when analysed for all autologous ovarian response categories with a higher rate of failed fertilisation in IVF treatment cycles (4.8%, 95% binomial exact 4.7 to 4.9%) when compared to ICSI treatment cycles (3.2%, 95% binomial exact 3.1 to 3.3%) (P\u00a0&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title><jats:p>The quality of data is reliant on the reporting system. Furthermore, success rates through ART have improved since 1991, with an increased number of blastocyst-stage embryo transfers. The inability to link the treatment cycle to the individual patient meant that we were unable to calculate the cumulative LB outcome per patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title><jats:p>This is the largest study to date which evaluates the impact of method of fertilisation in the POR patient and compares this to all autologous ovarian response categories. The results demonstrate that ICSI does not confer any benefit in improving reproductive outcomes in the absence of male factor subfertility, with no improvement seen in the clinical pregnancy or LB outcomes following a fresh treatment cycle.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title><jats:p>The study received no funding. C.M.B. is a member of the independent data monitoring group for a clinical endometriosis trial by ObsEva. He is on the scientific advisory board for Myovant and medical advisory board for Flo Health. He has received research grants from Bayer AG, MDNA Life Sciences, Volition Rx and Roche Diagnostics as well as from Wellbeing of Women, Medical Research Council UK, the NIH, the UK National Institute for Health Research and the European Union. He is the current Chair of the Endometriosis Guideline Development Group for ESHRE and was a co-opted member of the Endometriosis Guideline Group by the UK National Institute for Health and Care Excellence (NICE). I.G. has received research grants from Bayer AG, Wellbeing of Women, the European Union and Finox.<\/jats:p><\/jats:sec><jats:sec><jats:title>TRIAL REGISTRATION NUMBER<\/jats:title><jats:p>Not applicable.<\/jats:p><\/jats:sec>","DOI":"10.1093\/humrep\/dez301","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T12:38:59Z","timestamp":1583930339000},"page":"583-594","source":"Crossref","is-referenced-by-count":45,"title":["ICSI does not improve reproductive outcomes in autologous ovarian response cycles with non-male factor subfertility"],"prefix":"10.1093","volume":"35","author":[{"given":"P R","family":"Supramaniam","sequence":"first","affiliation":[{"name":"John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Granne","sequence":"first","affiliation":[{"name":"John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK"},{"name":"Oxford Endometriosis CaRe Centre, Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK"},{"name":"Oxford Reproductive Medicine, The Manor Hospital, Oxford OX3 7RP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E O","family":"Ohuma","sequence":"first","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK"},{"name":"Centre for Global Child Health & Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, Canada M5G 2L3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L N","family":"Lim","sequence":"first","affiliation":[{"name":"John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK"},{"name":"Oxford Reproductive Medicine, The Manor Hospital, Oxford OX3 7RP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"McVeigh","sequence":"first","affiliation":[{"name":"John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK"},{"name":"Oxford Endometriosis CaRe Centre, Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK"},{"name":"Oxford Reproductive Medicine, The Manor Hospital, Oxford OX3 7RP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Venkatakrishnan","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby DE22 3NE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Becker","sequence":"first","affiliation":[{"name":"John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK"},{"name":"Oxford Endometriosis CaRe Centre, Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK"},{"name":"Oxford Reproductive Medicine, The Manor Hospital, Oxford OX3 7RP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mittal","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Wolfson Fertility Center, St Mary\u2019s and Hammersmith Hospitals, Imperial College Healthcare NHS Trust, London W2 1NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2020033016151994800_ref1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/humrep\/deg159","article-title":"The use of ICSI for all cases of in-vitro conception","volume":"18","author":"Abu-Hassan","year":"2003","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref53","year":"2013"},{"key":"2020033016151994800_ref2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1472-6483(10)60196-4","article-title":"Embryo implantation rates in natural and stimulated assisted reproduction treatment cycles in poor responders","volume":"17","author":"Ata","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2020033016151994800_ref3","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0140-6736(00)05179-5","article-title":"Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial","volume":"357","author":"Bhattacharya","year":"2001","journal-title":"Lancet"},{"key":"2020033016151994800_ref4","doi-asserted-by":"crossref","first-page":"e82249","DOI":"10.1371\/journal.pone.0082249","article-title":"Factors associated with failed treatment: an analysis of 121,744 women embarking on their first IVF cycles","volume":"8","author":"Bhattacharya","year":"2013","journal-title":"PLoS One"},{"key":"2020033016151994800_ref5","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/humrep\/17.10.2600","article-title":"Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters","volume":"17","author":"Bonduelle","year":"2002","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.fertnstert.2007.04.055","article-title":"Do sperm DNA integrity tests predict pregnancy with in vitro fertilization?","volume":"89","author":"Collins","year":"2008","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref54","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/humupd\/dmp048","article-title":"World Health Organization reference values for human semen characteristics.","volume":"16","author":"Cooper","year":"2010","journal-title":"Human Reproduction Update"},{"key":"2020033016151994800_ref8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1008095","article-title":"Reproductive technologies and the risk of birth defects","volume":"366","author":"Davies","year":"2012","journal-title":"N Engl J Med"},{"key":"2020033016151994800_ref9","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/j.1471-0528.2010.02731.x","article-title":"The effect on human sex ratio at birth by assisted reproductive technology (ART) procedures--an assessment of babies born following single embryo transfers, Australia and New Zealand, 2002-2006","volume":"117","author":"Dean","year":"2010","journal-title":"BJOG"},{"key":"2020033016151994800_ref10","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10815-005-1496-2","article-title":"Modified natural cycle using GnRH antagonist can be an optional treatment in poor responders undergoing IVF","volume":"22","author":"Elizur","year":"2005","journal-title":"J Assist Reprod Genet"},{"key":"2020033016151994800_ref12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fendo.2018.00461","article-title":"Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria-the why","volume":"9","author":"Esteves","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2020033016151994800_ref13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.fertnstert.2007.10.066","article-title":"Data analysis of two in vivo fertility studies using Sperm Chromatin Structure Assay-derived DNA fragmentation index vs. pregnancy outcome","volume":"90","author":"Evenson","year":"2008","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/humrep\/dew092","article-title":"Santa Claus in the fertility clinic","volume":"31","author":"Evers","year":"2016","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref15","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref16","first-page":"2017","article-title":"European Ivf-monitoring consortium ftESoHR et al. trends over 15 years in ART in Europe: an analysis of 6 million cycles","author":"Ferraretti","year":"2017","journal-title":"Hum Reprod Open"},{"key":"2020033016151994800_ref17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/humrep\/den112","article-title":"Nuclear organization in human sperm: preliminary evidence for altered sex chromosome centromere position in infertile males","volume":"23","author":"Finch","year":"2008","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10815-005-9008-y","article-title":"A prospective randomized trial of conventional in vitro fertilization versus intracytoplasmic sperm injection in unexplained infertility","volume":"23","author":"Foong","year":"2006","journal-title":"J Assist Reprod Genet"},{"key":"2020033016151994800_ref19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/humrep\/den398","article-title":"Management of endometriomas in women requiring IVF: to touch or not to touch","volume":"24","author":"Garcia-Velasco","year":"2009","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref20","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1093\/humrep\/dew247","article-title":"Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates","volume":"31","author":"Grimstad","year":"2016","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref21","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.fertnstert.2016.02.001","article-title":"Evidence-based approach to unexplained infertility: a systematic review","volume":"105","author":"Gunn","year":"2016","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejogrb.2014.10.037","article-title":"Fertilization failure after IVF in 304 couples--a case-control study on predictors and long-term prognosis","volume":"184","author":"Krog","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020033016151994800_ref23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/humrep\/deg217","article-title":"Safety issues in assisted reproduction technology. From theory to reality--just what are the data telling us about ICSI offspring health and future fertility and should we be concerned?","volume":"18","author":"Kurinczuk","year":"2003","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref24","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/humrep\/deg361","article-title":"Safety issues in assisted reproductive technology: aetiology of health problems in singleton ART babies","volume":"18","author":"Lambert","year":"2003","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/humrep\/dey118","article-title":"ICSI does not increase the cumulative live birth rate in non-male factor infertility","volume":"33","author":"Li","year":"2018","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0015-0282(16)56697-7","article-title":"Complete failure of fertilization in couples with mechanical infertility: implications for subsequent in vitro fertilization cycles","volume":"61","author":"Lipitz","year":"1994","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref27","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/oxfordjournals.humrep.a135758","article-title":"Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles","volume":"10","author":"Liu","year":"1995","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10815-011-9614-9","article-title":"Should ICSI be recommended routinely in patients with four or fewer oocytes retrieved?","volume":"28","author":"Luna","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"2020033016151994800_ref29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.rbmo.2012.09.003","article-title":"ICSI increases ongoing pregnancy rates in patients with poor response cycle: multivariate analysis of 2819 cycles","volume":"25","author":"Maman","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2020033016151994800_ref30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/molehr\/6.11.1049","article-title":"Study of DNA-methylation patterns at chromosome 15q11-q13 in children born after ICSI reveals no imprinting defects","volume":"6","author":"Manning","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"2020033016151994800_ref31","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/humrep\/dez133","article-title":"Perinatal outcomes in singleton live births after fresh blastocyst-stage embryo transfer: a retrospective analysis of 67 147 IVF\/ICSI cycles","volume":"34","author":"Marconi","year":"2019","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0015-0282(16)54486-0","article-title":"The predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt","volume":"56","author":"Molloy","year":"1991","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref33","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/humrep\/13.8.2126","article-title":"Intracytoplasmic sperm injection as a routine indication in low responder patients","volume":"13","author":"Moreno","year":"1998","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref34","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.fertnstert.2003.11.031","article-title":"A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization","volume":"81","author":"Morgia","year":"2004","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/oxfordjournals.humrep.a019000","article-title":"Associations between ultrasound indices of follicular blood flow, oocyte recovery and preimplantation embryo quality","volume":"11","author":"Nargund","year":"1996","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/humupd\/dmn032","article-title":"Trends in the use of intracytoplasmatic sperm injection marked variability between countries","volume":"14","author":"Nyboe Andersen","year":"2008","journal-title":"Hum Reprod Update"},{"key":"2020033016151994800_ref37","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0015-0282(16)55867-1","article-title":"Sperm characteristics and outcome of human assisted fertilization by subzonal insemination and intracytoplasmic sperm injection","volume":"59","author":"Palermo","year":"1993","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.rbmo.2013.11.010","article-title":"Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF\/ICSI","volume":"28","author":"Polyzos","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2020033016151994800_ref39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.fertnstert.2012.08.026","article-title":"Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion","volume":"98","author":"Practice Committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology","year":"2012","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.fertnstert.2009.10.046","article-title":"Sperm DNA fragmentation: mechanisms of origin, impact on reproductive outcome, and analysis","volume":"93","author":"Sakkas","year":"2010","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0015-0282(16)58081-9","article-title":"A model for the incorporation of intracytoplasmic sperm injection into a private practice in vitro fertilization program","volume":"65","author":"Schoolcraft","year":"1996","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/and.12291","article-title":"Comparison of conventional in vitro fertilisation and intracytoplasmic sperm injection outcomes in patients with moderate oligoasthenozoospermia","volume":"47","author":"Shuai","year":"2015","journal-title":"Andrologia"},{"key":"2020033016151994800_ref43","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/humrep\/deu053","article-title":"Association between response to ovarian stimulation and miscarriage following IVF: an analysis of 124 351 IVF pregnancies","volume":"29","author":"Sunkara","year":"2014","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref44","first-page":"2019","article-title":"Secondary sex ratio in assisted reproduction: an analysis of 1 376 454 treatment cycles performed in the UK","author":"Supramaniam","year":"2019","journal-title":"Hum Reprod Open"},{"key":"2020033016151994800_ref45","first-page":"119","article-title":"The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age","volume":"32","author":"Tannus","year":"2017","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-12-56","article-title":"Changes in sex ratio from fertilization to birth in assisted-reproductive-treatment cycles","volume":"12","author":"Tarin","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"2020033016151994800_ref47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0015-0282(16)57004-6","article-title":"Assisted fertilization with intracytoplasmic sperm injection","volume":"62","author":"Tsirigotis","year":"1994","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref48","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0140-6736(01)06679-X","article-title":"Conventional insemination versus intracytoplasmic sperm injection","volume":"358","author":"Tucker","year":"2001","journal-title":"Lancet"},{"key":"2020033016151994800_ref49","first-page":"CD001301","article-title":"Intra-cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in vitro fertilisation in patients with non-male subfertility","author":"Rumste","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2020033016151994800_ref50","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/oxfordjournals.humrep.a138192","article-title":"High fertilization and implantation rates after intracytoplasmic sperm injection","volume":"8","author":"Van Steirteghem","year":"1993","journal-title":"Hum Reprod"},{"key":"2020033016151994800_ref51","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.fertnstert.2013.06.035","article-title":"Management of the first in vitro fertilization cycle for unexplained infertility: a cost-effectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection","volume":"100","author":"Vitek","year":"2013","journal-title":"Fertil Steril"},{"key":"2020033016151994800_ref52","first-page":"1786","article-title":"The international glossary on infertility and fertility Care","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"2017 Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/3\/583\/32980929\/dez301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/3\/583\/32980929\/dez301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T10:45:37Z","timestamp":1666089937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/3\/583\/5802950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,11]]},"published-print":{"date-parts":[[2020,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dez301","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,3]]}}}